secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001104659-25-065009
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana closes Prospect Health acquisition for $708M, updates FY 2025 guidance
------------------------------------------------------------------------------

- Purchase price reduced from $745M to $708M; closed July 1, 2025.
- Expects Prospect to contribute ~$1.2B revenue and $81M adjusted EBITDA annually.
- Updated FY 2025 guidance: revenue $3.1B-$3.3B, adjusted EBITDA $215M-$225M.
- Post-close net debt ~$700M; target net leverage below 2.5x within 12-18 months.
- Reiterates Q2 2025 guidance; expects $12M-$15M synergies over 12-18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925065009/0001104659-25-065009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465925065009/tm2519514d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-065009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer